
New insight into ALS disease origins leads to targeted novel therapies
New insight into ALS disease origins leads to targeted novel therapies The Thierry Latran Foundation selected in 2013 the innovative project: Normalization of the blood-brain barrier deficiency in ALS with inhibitors of the Platelet-Derived Growth Factor CC (PDGF-CC) pathway. The...